Teltas A Tablet belongs to the class of anti-hypertensive drugs, primarily used to treat high blood pressure (hypertension). Hypertension is a medical condition in which blood pressure is elevated persistently in the arteries. It is considered an essential risk factor for cardiovascular diseases. Teltas A Tablet lowers the blood pressure by widening and relaxing blood vessels.

Teltas A Tablet is a fixed-dose combination composed of two medicines, namely, Telmisartan and Amlodipine. Telmisartan belongs to a group of drugs called angiotensin II receptor antagonists. It lowers blood pressure and increases blood flow by preventing the narrowing of blood vessels. It is used to lower the chances of stroke, heart attack, and death. Amlodipine is a calcium channel blocker that dilates (widens) blood vessels and increases blood flow. Altogether, it helps to lower high blood pressure, chest pain (angina), and other conditions caused by coronary artery disease.

Teltas A Tablet is available in the form of oral tablets. Swallow it as a whole with a glass of water. You can take Teltas A Tablet with or without food once a time in a day, as prescribed by the doctor. Do not crush, chew, or break it. Your doctor will decide the dosage based on your medical condition. In some cases, Teltas A Tablet can cause side effects primarily peripheral oedema (swelling in legs and arms), a common cold, backache, diarrhoea, dizziness, drowsiness, confusion, rashes, and weakness. Most of these side effects of Teltas A Tablet do not require medical attention and gradually resolve over time. However, if these side effects persist longer, please consult your doctor.

If you are known to be allergic to Teltas A Tablet or any other medicines, please inform your doctor. Before taking Teltas A Tablet , let your doctor know if you have hypersensitivity like anaphylaxis (an allergic reaction which includes rashes, low pulse, and shock) or angioedema (swelling under the skin mostly swelling occurs in the face, tongue, abdomen, legs and arms). Pregnant or breastfeeding women should discontinue this Teltas A Tablet because it can cause injury and death to the developing fetus. Please do not stop taking Teltas A Tablet on your own, as it may lead to the recurrence of symptoms or worsen the condition. Do not consume alcohol with Teltas A Tablet as it may increase the risk of low blood pressure. Avoid potassium supplements with Teltas A Tablet as it may lead to high potassium levels in the blood.

Teltas A Tablet is an anti-hypertensive drug that treats high blood pressure (hypertension). Teltas A Tablet lowers blood pressure by widening and relaxing blood vessels. Teltas A Tablet consists of two medicines, namely: Telmisartan and Amlodipine. Telmisartan belongs to a group of drugs called angiotensin II receptor antagonists. It lowers blood pressure and increases blood flow by preventing the narrowing of blood vessels. It reduces the chances of stroke, heart attack, and death. Amlodipine is a calcium channel blocker that dilates (widens) blood vessels and increases blood flow. Altogether, it helps to lower high blood pressure, chest pain (angina), and other conditions caused by coronary artery disease.

Monitor your blood pressure levels regularly. If you are known to be allergic to Teltas A Tablet or have any kidney or liver problems or severe dehydration, please inform your doctor beforehand. Pregnant or breastfeeding women should also consult their doctor before taking it. It is advised to complete the prescribed course, even if you feel better. Complete the course strictly as suggested by the doctor, even if you feel better, to avoid disease recurrence. Avoid consumption of alcohol with Teltas A Tablet as it may increase the risk of low blood pressure. Avoid potassium supplements with Teltas A Tablet as they may lead to high potassium levels in the blood.

• Keep a check on your daily blood pressure, and if you notice any fluctuations, please consult a doctor. A low salt/sodium diet and regular exercise are recommended along with Teltas A Tablet for effective results.